Cipla rallies 4% as US arm acquires rights of key anti-infective dru...

07/25/19

Cipla rallies 4% as US arm acquires rights of key anti-infective drug Zemdri  Moneycontrol

Shares of pharma company Cipla rallied nearly four percent intraday on July 25 after its US subsidiary acquired worldwide rights, excluding Greater China, ...

[more]